These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 10746706)
21. Characterization of the Engrailed mutant mice as experimental models for Parkinson's disease. Sgadò P; Viaggi C; Fantacci C; Corsini GU Parkinsonism Relat Disord; 2008; 14 Suppl 2():S103-6. PubMed ID: 18585948 [TBL] [Abstract][Full Text] [Related]
22. A new link between pesticides and Parkinson's disease. Giasson BI; Lee VM Nat Neurosci; 2000 Dec; 3(12):1227-8. PubMed ID: 11100135 [No Abstract] [Full Text] [Related]
23. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Lotharius J; Brundin P Nat Rev Neurosci; 2002 Dec; 3(12):932-42. PubMed ID: 12461550 [No Abstract] [Full Text] [Related]
25. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148 [TBL] [Abstract][Full Text] [Related]
26. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. Schlossmacher MG; Cullen V; Müthing J N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719451 [No Abstract] [Full Text] [Related]
27. New hope for mechanism-based treatment of Parkinson's disease. Bradbury J Drug Discov Today; 2005 Jan; 10(2):80-1. PubMed ID: 15718152 [TBL] [Abstract][Full Text] [Related]
28. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958 [TBL] [Abstract][Full Text] [Related]